Evidence map›Paper›PMID 31372195›Full record

ArticleBiomicrofluidics2019

Bi-layer blood vessel mimicking microfluidic platform for antitumor drug screening based on co-culturing 3D tumor spheroids and endothelial layers.

Wentao Shi, Lara Reid, Yongyang Huang, Christopher G Uhl, Ran He, Chao Zhou, Yaling Liu

Abstract read
In one paragraph

Article in Biomicrofluidics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Advanced Multi-Dimensional Cellular Models as Emerging Reality to ReproduceInternational journal of molecular sciences · 2021
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wentao ShiDepartment of Bioengineering, Lehigh University, Bethlehem, Pennsylvania 18015, USA.
Lara ReidDepartment of Bioengineering, Lehigh University, Bethlehem, Pennsylvania 18015, USA.
Yongyang HuangDepartment of Electrical and Computer Engineering, Lehigh University, Bethlehem, Pennsylvania 18015, USA.
Christopher G UhlDepartment of Bioengineering, Lehigh University, Bethlehem, Pennsylvania 18015, USA.
Ran HeDepartment of Mechanical Engineering and Mechanics, Lehigh University, Bethlehem, Pennsylvania 18015, USA.
Chao Zhou
Yaling Liu

Funding

Supplement: Hemolysis Prediction Software DevelopmentR01HL131750 · NHLBI · LEHIGH UNIVERSITY · PI LIU, YALING · 2017 to 2021
$2.2M
High throughput optical coherence tomography (OCT)-based imaging platform for label-free, non-invasive characterization of 3D tumor spheroids.R01EB025209 · NIBIB · WASHINGTON UNIVERSITY · PI ZHOU, CHAO · 2017 to 2021
$1.4M
NHLBI NIH HHS R01 HL131750NIBIB NIH HHS R01 EB025209
6 · The paper itself

Abstract

Two-dimensional (2D) cell culture is not ideal for traditional drug screening, because 2D culture does not accurately mimic the physiological microenvironment of tumor cells. Thus, a drug-screening system which more closely mimics the microenvironment of

Identifiers

PMID31372195
PMCPMC6669041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.